Please assess the completion status of the following clinical trial:

Trial Title: Controlling Oral Malodor by ClōSYS® Oral Rinse

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Completion of the Informed Consent.~* Must be able to follow verbal/written instructions.~* Between 21 to 65 years of age, male or female.~* Has normal oral interior cheek wall tissues.~* In good general health.~* Should not have any severe or debilitating disease that may impede participation.~* Average organoleptic intensity rating of at \>2.6 but \<4.5 on an intensity scale of 0-5.~Exclusion Criteria:~* Pregnant or nursing.~* Diagnosis of Xerostomia, including medication induced Xerostomia.~* Oral or extraoral piercing that interferes with the clinical assessments in the mouth.~* Fixed or removable oral appliance.~* Advanced periodontal disease or excessive gingival recession.~* Known allergy or sensitivity to study products.~* Unwilling to abstain from all oral hygiene products other than those prescribed for the study.~* Heavy deposits of calculus, either supragingival and/or subgingival.~* History of severe transmittable infectious disease e.g. hepatitis, HIV, tuberculosis.~* Medical or dental condition that would be unduly affected by participation in this study.~* Any other condition that may interfere with the study.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Test-Unflavored Rinse (Type: ACTIVE_COMPARATOR): CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution.
- Test-Flavored Rinse (Type: ACTIVE_COMPARATOR): CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution with mint flavoring.
- Placebo (Type: PLACEBO_COMPARATOR): CloSYS Oral Rinse product (no chlorine dioxide)

Based on this trial design, predict the completion outcome and termination type (if applicable).